Cargando…
Recurrence of Autoimmune Hepatitis After COVID-19 Vaccination
A 35-year-old Asian female with a pertinent past medical history of autoimmune hepatitis presented with an acute recurrence of autoimmune hepatitis two weeks after receiving the second dose of the Pfizer-BioNTech messenger RNA (mRNA) coronavirus disease 2019 (COVID-19) vaccine. Nine cases of autoimm...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9236645/ https://www.ncbi.nlm.nih.gov/pubmed/35774705 http://dx.doi.org/10.7759/cureus.25339 |
_version_ | 1784736580387209216 |
---|---|
author | Brubaker, Jon Elliott D Casaccio, Christopher L Brazeau, Michael J |
author_facet | Brubaker, Jon Elliott D Casaccio, Christopher L Brazeau, Michael J |
author_sort | Brubaker, Jon Elliott D |
collection | PubMed |
description | A 35-year-old Asian female with a pertinent past medical history of autoimmune hepatitis presented with an acute recurrence of autoimmune hepatitis two weeks after receiving the second dose of the Pfizer-BioNTech messenger RNA (mRNA) coronavirus disease 2019 (COVID-19) vaccine. Nine cases of autoimmune hepatitis after the administration of the COVID-19 vaccine have been reported, but this is the first documented case of a reactivation of autoimmune hepatitis in remission. As recommendations for COVID-19 vaccinations and booster shots continue to evolve, all adverse events should be reported to better educate and monitor patients. |
format | Online Article Text |
id | pubmed-9236645 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-92366452022-06-29 Recurrence of Autoimmune Hepatitis After COVID-19 Vaccination Brubaker, Jon Elliott D Casaccio, Christopher L Brazeau, Michael J Cureus Internal Medicine A 35-year-old Asian female with a pertinent past medical history of autoimmune hepatitis presented with an acute recurrence of autoimmune hepatitis two weeks after receiving the second dose of the Pfizer-BioNTech messenger RNA (mRNA) coronavirus disease 2019 (COVID-19) vaccine. Nine cases of autoimmune hepatitis after the administration of the COVID-19 vaccine have been reported, but this is the first documented case of a reactivation of autoimmune hepatitis in remission. As recommendations for COVID-19 vaccinations and booster shots continue to evolve, all adverse events should be reported to better educate and monitor patients. Cureus 2022-05-25 /pmc/articles/PMC9236645/ /pubmed/35774705 http://dx.doi.org/10.7759/cureus.25339 Text en Copyright © 2022, Brubaker et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Internal Medicine Brubaker, Jon Elliott D Casaccio, Christopher L Brazeau, Michael J Recurrence of Autoimmune Hepatitis After COVID-19 Vaccination |
title | Recurrence of Autoimmune Hepatitis After COVID-19 Vaccination |
title_full | Recurrence of Autoimmune Hepatitis After COVID-19 Vaccination |
title_fullStr | Recurrence of Autoimmune Hepatitis After COVID-19 Vaccination |
title_full_unstemmed | Recurrence of Autoimmune Hepatitis After COVID-19 Vaccination |
title_short | Recurrence of Autoimmune Hepatitis After COVID-19 Vaccination |
title_sort | recurrence of autoimmune hepatitis after covid-19 vaccination |
topic | Internal Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9236645/ https://www.ncbi.nlm.nih.gov/pubmed/35774705 http://dx.doi.org/10.7759/cureus.25339 |
work_keys_str_mv | AT brubakerjonelliottd recurrenceofautoimmunehepatitisaftercovid19vaccination AT casacciochristopherl recurrenceofautoimmunehepatitisaftercovid19vaccination AT brazeaumichaelj recurrenceofautoimmunehepatitisaftercovid19vaccination |